INDV

Indivior
INDV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£1.05B
EV
£1.05B
Shares Outstanding
124.77M
Beta
0.34

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£14.43
P/E 2025E
9.29x
P/Revenue 2025E
1.35x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Indivior PLC

gainify
INDV

Indivior PLC

INDV

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. T...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Crossley, Mark

Employees

1,041

IPO Date

2014-12-22

Headquarters

10710 Midlothian Turnpike, Suite 125, North Chesterfield, Virginia, 23235, United States

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.